Introduction
Opioids are frequently used in critically ill children and neonates for sedation and analgesia in the intensive care setting [1, 3] . However, prolonged therapy often leads to tolerance and withdrawal symptoms when opioids are weaned or discontinued [11, 36, 40] . Crosstalk between the pathways underlying opioid tolerance and hyperalgesia has also been proposed, suggesting that a common cellular mechanism may be causal in both conditions [18, 20] .
Some rat studies have shown that morphine exposure during the neonatal period can promote changes in pain signaling pathways [32, 37] . Sweitzer et al. [37] demonstrated that acute administration in young rats produces spontaneous or precipitated withdrawalassociated pain hypersensitivity. Recently, our group showed that repeated morphine exposure in early life promotes a hyperalgesic response to noxious events in the adult life of rats; this increased nociceptive response was reversed by a NMDA receptor antagonist [32] , suggesting that early morphine exposure reduced the nociceptive threshold due to possible adaptations in the glutamatergic system.
Glutamate is a major excitatory neurotransmitter in primary afferent terminals and plays a critical role in normal spinal excitatory synaptic transmission [8, 17, 33, 43, 46] by glutamate transporters (GTs) in the plasma membranes of both neurons and glia [23, 24] , and it is crucial for nociception transmission and for the prevention of glutamate-induced neurotoxicity. Changes in glutamate uptake have been implicated in peripheral nervous system damage [14, 19] , neuropathic pain [35] and hyperalgesia [44, 45] .
Taking into account that morphine exposure in early life can lead to changes in nociceptive behavior response in adult life, and that this effect is reversed by administration of a glutamatergic receptor antagonist, this study sought to assess the long-term effect of neonatal repeated morphine treatment on glutamate uptake in the spinal synaptosomes of rats in adulthood.
Materials and methods
At birth, litters were standardized to contain up to 8 pups per dam, and pups remained with their mothers until 21 days of age. Eight-day-old male Wistar rats were divided into two groups: saline control (C) and morphine-treated (M). Rats at P8 were chosen because it is accepted that animals in this age are at a similar stage of neurological development to that of a human newborn [10] . It is also accepted that they are in a physiologically immature state [26] , since this period is characterized by major developmental changes in the brain and plasticity of the developing pain system [4, 13, 27] . Animal handling and all experiments were performed in accordance with international guidelines for animal welfare. Each animal received saline (control group) or morphine (5 g s.c. in the mid-scapular area; morphine group) starting at P8, then once daily for 7 days. This dose was chosen on the basis of a previous study by Rozisky et al. [30] [31] [32] . The experimental assays were performed when the animals were 30 and 60 days old.
Two (P30) and 5 weeks (P60) after the end of neonatal morphine treatment the animals were decapitated. The spinal cord was rapidly removed, dissected out on ice, and gently homogenized in 10 vol. of ice-cold medium consisting of 320 mM sucrose, 1 mM EDTA, and 0.25 mM dithiothreitol, pH 7.4, with a motor-driven Teflon-glass homogenizer. The synaptosomal fraction was isolated on a discontinuous Percoll gradient, according to Dunkley et al. [9] . Protein concentration was measured using the Lowry method [16] . The entire spinal cord was used and a pool from two rats was used for each one synaptosomes assay, due to low yield of the enriched fraction in viable synaptosomes. The material was prepared fresh daily and kept at 0-4 • C throughout the experiment.
Determination of Na + -dependent high-affinity glutamate uptake was performed as described by Leal et al. with minor modifications [15] . Synaptosomal preparations were washed twice through resuspension in 3 vol. of 300 mM sucrose with 15 mM Tris/acetate buffer (pH 7.4) and centrifugation at 13,000 × g for 15 min at 4 • C. The final pellet was resuspended in 300 mM sucrose with 15 mM Tris/acetate buffer (pH 7.4) and incubated in HBSS (Hepes/Cl buffered salt solution) pH 7.4 (containing 27 mM HEPES, 133 mM NaCl, 2.4 mM KCl, 1.2 mM MgSO 4 , 1.2 mM KH 2 PO 4 , 12 mM glucose, 1.0 mM CaCl 2 ) in the presence of 2 M of l-[3H] glutamic acid (PerkinElmer, Inc., MA, USA, specific activity 1.48-2.96 TBq/mmol) for 1 min at 37 • C. The reaction was stopped by filtration through GF/B glass microfiber filters (Whatman). The filters were washed three times with 3 ml of ice-cold 15 mM Tris/acetate buffer (pH 7.4) in 155 mM ammonium acetate, and the radioactivity retained on the filters was measured in a Wallac scintillation counter. Specific [3H] glutamate uptake was calculated as the difference between uptake obtained in the incubation medium as described above and uptake obtained with a similar incubation medium containing choline chloride instead of NaCl (nonspecific uptake). Na + -independent uptake was less than 10% of the total. All measurements were made in triplicate. The results were expressed as percentage of [3H] glutamate uptake obtained on control group, which was considered as 100%. The between-group comparisons were performed with Student's t-test for independent samples. Differences were considered statistically significant if P < 0.05.
Results
After repeated morphine treatment in early life, from P8 to P14, [3H]-glutamate uptake in spinal synaptosomes was assessed at P30 and P60. In both ages, animals that had received morphine exhibited decreased [3H]-glutamate uptake as compared with control animals that had received saline (P30: C = 100.0 ± 29.0% of [3H] glutamate uptake, M = 12.96 ± 3.66% of [3H] glutamate uptake obtained on control group, Student's t-test, P = 0.019; P60: C = 100.0 ± 22.63% of [3H] glutamate uptake, M = 31.37 ± 7.06% of [3H] glutamate uptake obtained on control group; Student's t-test, P = 0.04, Fig. 1 , Panels A and B).
Discussion
In this study, once-daily, low-dose morphine administration in early life, from P8 to P14, decreased [3H]-glutamate uptake in spinal synaptosomes P30 and P60. This result suggests that opioid exposure during development of the central nervous system leads to long-lasting adaptations in the glutamatergic system.
Our group has suggested that newborn rats may be more sensitive to low doses of morphine [31] because there is extensive remodeling of opioid receptor expression in the first 3 postnatal weeks [2, 28, 29] . At P14, spinal -opioid receptors (ORs) are restricted to the dorsal horn, whereas they appear throughout the spinal grey matter at P7, and the density of binding decreases in the first 3 postnatal weeks, with peak binding at P7, that then falls to adult levels by P21 [2] . This abundance of ORs in early postnatal life could explain why exposure to morphine for 7 days, from P8 to P14, produces analgesia instead of tolerance [31] . Thus, the greater expression of ORs at P7 in comparison to adult rats suggests a more widespread effect of morphine, acting both directly within the spinal cord and indirectly through larger termination profiles of primary afferents (for a review, see [22] ). This, coupled with the overexpression of excitatory amino acid receptors at the primary afferent-spinal cord synapse, supports a potential role for ORs in the normal maturation of nociceptive circuitry; hence, disruption of this by administration of exogenous opioid agonists may have detrimental consequences for the maturation of pain circuitry [38, 39] .
Some studies have shown that repeated opioid administration leads to possible neural adaptations that may underlie opioid-induced paradoxical pain [12, 41, 42] . Recently, we showed that early morphine treatment increases nociceptive behavioral responses at P30 and P60 in a rat formalin tonic pain model. Remarkably, these behavioral changes were reverted by administration of a NMDA receptor antagonist in both ages, suggesting direct involvement of the glutamatergic system in opioid-induced nociception [32] .
The homeostasis of extracellular glutamate is tightly regulated by glutamate transporters (GTs) in the plasma membranes of both neurons and glia [21] . The three glutamate transport protein subtypes isolated in the spinal cord (GLAST, GLT-1, EAAC1) are considered essential to the maintenance of low resting levels of glutamate (<1 mM) and the prevention of overstimulation of glutamate receptors [21] . Notably, these glutamate transporters are concentrated in the superficial dorsal horn of the spinal cord and account for >80% of total glutamate transport [7] . Several studies indicate that GTs play a crucial role in the prevention of glutamate neurotoxicity under both physiological and pathological conditions ( [21] , for review see [7] ). The competitive opioid antagonist naloxone decreases GLT-1 mRNA in brain regions and is involved in the expression of morphine withdrawal symptoms [25] .
Recently, another study showed that morphine exposure in adult rats leads to downregulation of spinal glutamate GLT-1 transporter and is involved in the generation of opioid-induced hyperalgesia [6] . In addition, it bears stressing that synaptosomes have been widely used to investigate glutamate uptake; but the specific glutamate transporters present in the synaptosomal preparation are still a matter of controversy. However, pharmacological analysis using different types of transporter blockers suggests that this uptake aligns most closely with that of the GLT-1 transporter [34] (for a review, see [5, 7] ). Thus, one might suggest that the decreased [3H]-glutamate reuptake observed in spinal synaptosomes after neonatal repeated morphine treatment (P30 and P60) would lead to increased extracellular glutamate levels in the spinal cord synaptic cleft. This, in turn, may increase excitatory amino acid receptor activation (including NMDA). These considerations can explain, at least in part, the increase in nociceptive behavioral responses at P30 and P60 induced by early-life morphine treatment in this rat model.
In conclusion, the findings presented here added new insights to our previous studies [32] , suggesting that repeated morphine exposure in early life leads to long-lasting adaptations in glutamatergic signaling, due to a decrease in [3H]-glutamate uptake in spinal synaptosomes at P30 and P60. This result may be associated with increased levels of excitatory amino acids and potential hyperactivity of glutamatergic receptors, such as the NMDA receptor, which, in turn, leads to a hyperalgesic response in adult life. Furthermore, this study highlights the importance of continuing research in this field to provide comprehensive knowledge of the long-term effects of morphine administration in early life.
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